CohBar, Inc. (NASDAQ:CWBR – Get Free Report) traded up 1% during trading on Wednesday . The stock traded as high as $0.53 and last traded at $0.53. 1,324 shares changed hands during trading, a decline of 50% from the average session volume of 2,672 shares. The stock had previously closed at $0.52.
CohBar Stock Performance
The firm’s 50 day simple moving average is $0.50 and its 200 day simple moving average is $0.49.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Featured Articles
- Five stocks we like better than CohBar
- Using the MarketBeat Stock Split Calculator
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- How to trade using analyst ratings
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Are Dividend Challengers?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
